FDA chief will testify at first meningitis hearing

(AP)—House lawmakers investigating a nationwide outbreak of deadly meningitis are asking the head of the Food and Drug Administration to testify at the first congressional hearing on the issue next week.

The Energy & Commerce Committee says FDA Commissioner Dr. Margaret Hamburg will appear before the committee on Nov. 14.

More than 400 people have been sickened by contaminated steroid shots distributed by New England Compounding Center, according to the Centers for Disease Control and Prevention. Twenty nine people have died.

Committee staffers say they have also invited Barry Cadden, co-founder of the compounding center, the specialty pharmacy linked to the . The committee has also invited James Coffey, director of the Massachusetts Board of Registration in Pharmacy. Staffers say they are awaiting replies from Cadden and Coffey.

0 shares

Related Stories

2nd firm agrees to temporary shutdown in outbreak

date Oct 10, 2012

(AP)—A Massachusetts company run by the same executives who operated a specialty pharmacy linked to a fatal meningitis outbreak has agreed to temporarily shut down for inspection by state and federal regulators.

US pharmacy linked to outbreak issues wide recall

date Oct 07, 2012

(AP)—The pharmacy that distributed a steroid linked to an outbreak of fungal meningitis has issued a voluntary recall of all of its products, calling the move a precautionary measure.

Recommended for you

Score IDs patients with upper extremity DVT at low risk

date 1 hour ago

(HealthDay)—For patients with upper-extremity deep vein thrombosis (DVT), six easily available factors can be used to create a score that identifies those at low risk of adverse events during the first ...

Combined drug treatment combats kidney disease

date 11 hours ago

A recent discovery by drug researchers whereby coupling specific cell membrane receptors has altered kidney cell function has triggered a re-think of how to treat chronic kidney disease (CKD) more effectively.

Active substance targeting dreaded hospital germs

date 11 hours ago

In the German Center for Infection Research (DZIF), scientists have conducted clinical studies on an active substance against the dreaded hospital pathogen Staphylococcus aureus: a highly effective protein from bacteriophages ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.